NEO
Neogenomics Inc
Price:  
13.17 
USD
Volume:  
1,464,071.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NEO Relative Valuation

-262.4%
Upside

As of 2024-06-22, the Relative Valuation of Neogenomics Inc (NEO) is (21.39) USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.17 USD, the upside of Neogenomics Inc based on Relative Valuation is -262.4%.

The range of the Relative Valuation is (20.03) - (21.35) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 30.4x - 37.4x 33.5x
Forward P/E multiples 29.1x - 32.4x 31.4x
Fair Price (20.03) - (21.35) (21.39)
Upside -252.1% - -262.1% -262.4%
13.17 USD
Stock Price
(21.39) USD
Fair Price

NEO Relative Valuation - Historical P/E Data

Date P/E
2024-06-21 -19.98
2024-06-20 -19.74
2024-06-18 -19.74
2024-06-17 -19.87
2024-06-14 -19.99
2024-06-13 -20.36
2024-06-12 -21.33
2024-06-11 -19.96
2024-06-10 -20.21
2024-06-07 -19.74
2024-06-06 -19.92
2024-06-05 -20.40
2024-06-04 -20.18
2024-06-03 -20.51
2024-05-31 -20.80
2024-05-30 -21.24
2024-05-29 -20.98
2024-05-28 -21.43
2024-05-24 -21.60
2024-05-23 -21.07
2024-05-22 -21.91
2024-05-21 -22.42
2024-05-20 -22.62
2024-05-17 -22.45
2024-05-16 -22.74
2024-05-15 -22.95
2024-05-14 -23.36
2024-05-13 -23.71
2024-05-10 -23.92
2024-05-09 -23.51
2024-05-08 -22.95
2024-05-07 -23.62
2024-05-06 -23.53
2024-05-03 -23.21
2024-05-02 -22.33
2024-05-01 -21.18
2024-04-30 -21.12
2024-04-29 -23.09
2024-04-26 -21.45
2024-04-25 -21.01
2024-04-24 -21.28
2024-04-23 -21.48
2024-04-22 -20.36
2024-04-19 -20.52
2024-04-18 -20.89
2024-04-17 -20.75
2024-04-16 -21.01
2024-04-15 -20.86
2024-04-12 -21.37
2024-04-11 -22.03